FFOX
FundX Future Fund Opportunities ETF
FundX Future Fund Opportunities ETF seeks to provide long-term capital appreciation by investing in a diversified portfolio of equity securities, including those of emerging companies and sectors poised for growth.
US
EQUITY
Active
MANAGEMENT STYLE
$ 219.6 M
ASSETS UNDER MGMT
100 bp
EXPENSES
Fund Basics
| Inception date | Jun 09, 2025 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | Yes |
Top 10 Holdings
Complete list +
| CASH & OTHER | 3.2 % |
| HALOZYME THERAPEUTICS INC | 3.0 % |
| MILLICOM INTL CELLULAR S.A. | 2.6 % |
| GUARDANT HEALTH, INC. | 2.5 % |
| IONIS PHARMACEUTICALS, INC. | 2.1 % |
| FIRSTCASH, INC. | 2.1 % |
| NANOMETRICS INC | 2.0 % |
| COHERENT INC | 2.0 % |
| BWX TECHNOLOGIES, INC. | 1.9 % |
| GLOBUS MEDICAL INC - A | 1.9 % |
Constituent Breakdown
| Number of holdings | 74 |
| Herfindahl-Hirschman Index | 10 |
| Wgt avg mkt cap (mns) | $0 |
| Large cap (>$10bn) | 0.0% |
| Mid cap ($2-10bn) | 0.0% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 91.7% |
| Emerging mkts. | 2.8% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 85.8 % |
 |
LUXEMBOURG | 2.6 % |
 |
CAYMAN ISLANDS | 1.8 % |
 |
CHINA | 1.7 % |
 |
BRITAIN | 1.5 % |
 |
BRAZIL | 1.1 % |
Historical Performance
Standardized Performance (as of 04/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 5.1% | -- | -- | -- | -- | -- | -- | 13.5% |
| Dividend Yield | 0.0% | -- | -- | -- | -- | -- | -- | 0.0% |
| Total Returns | 5.1% | -- | -- | -- | -- | -- | -- | 13.5% | Ann. Volatility | 21.5% | -- | -- | -- | -- | -- | -- | 17.8% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.00 | 0% |
| MSCI EAFE | 0.00 | 0% |
| MSCI Emg Mkts | 0.00 | 0% |
Liquidity Measures
| Avg. volume (000) | 17 |
| ADV traded (mns) | $0 |
| Turnover | 0.2% |
| Avg. Bid/Ask (% of price) | 0.15% |
Technical Indicators
| 30d moving avg. (EMA) | $27.96 |
| Relative strength (RSI) | 50 |
| MACD/Signal | -0.15/-0.09 |
| Bollinger Bands (Upper/Lower) | $29.12/$27.04 |
| Short interest (% of AUM) | 0.2% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. FFOX |
Expenses vs. FFOX |
ALTAR Score™ vs. FFOX |
|---|---|---|---|---|
| DBSC | Deepwater Beachfront Small Cap ETF | 21.4% | -15 bp | -1.4% |
| FFND | Future Fund Active ETF | 19.5% | 0 bp | +1.4% |
| RSMC | Rockefeller U.S. Small-Mid Cap ETF | 16.8% | -25 bp | +1.2% |
| MMSC | First Trust Multi-Manager Small Cap Opportunities ETF | 15.9% | -5 bp | -3.6% |
| XSMO | Invesco S&P SmallCap Momentum ETF | 15.2% | -61 bp | +0.6% |
| IJK | iShares S&P Mid-Cap 400 Growth ETF | 14.2% | -83 bp | +1.1% |
| MDYG | State Street SPDR S&P 400 Mid Cap Growth ETF | 14.0% | -85 bp | +1.1% |
| IVOG | Vanguard S&P Mid-Cap 400 Growth ETF | 13.8% | -90 bp | +1.1% |
| RFG | Invesco S&P Midcap 400 Pure Growth ETF | 13.7% | -65 bp | +1.7% |
| FSGS | First Trust SMID Growth Strength ETF | 13.3% | -40 bp | +2.5% |
Risk and Returns: FFOX vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 5/28/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
3.7%
ALTAR SCORE™
22nd
PERCENTILE
UNDERWEIGHT
ETFRC RATING
There are 1,399 funds in the US Equity category with an average
ALTAR Score™ of 5.3% and a standard deviation
of 2.1%. FFOX's ALTAR Score™ is approximately -0.8 standard
deviations above the category average. This places FFOX in the 22nd percentile
among funds in the category.
Sell-Side Consensus
$34.3
PRICE TARGET
+21.6%
UPSIDE